Jagsonpal Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 578.29 million compared to INR 605.26 million a year ago. Revenue was INR 621.5 million compared to INR 1,222.53 million a year ago. Net income was INR 74.72 million compared to INR 104.12 million a year ago. Basic earnings per share from continuing operations was INR 2.84 compared to INR 3.97 a year ago. Diluted earnings per share from continuing operations was INR 2.84 compared to INR 3.97 a year ago.
For the six months, sales was INR 1,179.82 million compared to INR 1,211.23 million a year ago. Revenue was INR 1,225.57 million compared to INR 2,424.48 million a year ago. Net income was INR 149.51 million compared to INR 133.34 million a year ago. Basic earnings per share from continuing operations was INR 5.7 compared to INR 5.09 a year ago. Diluted earnings per share from continuing operations was INR 5.68 compared to INR 5.09 a year ago.